BioWorld

Aug. 20, 2007

FDA Approves Anesiva's Zingo To Ease Pediatric Patient Pain

With the U.S. approval Friday of Anesiva's lidocaine product Zingo, hospitalized children will have something less to fear: needle sticks from i.v. insertions and blood draws. (BioWorld Today) Read More

Indevus: FDA Letter Declares Cancer Therapy 'Approvable'

As Biogenerics Debate Evolves, The More It Remains The Same

Relationship Of Aneuploidy To Growth, Cancer Risk "Complex"

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Feb. 4, 2025.

Today's news in brief

Briefs

BioWorld MedTech briefs for Jan. 30, 2026.

Illustration of brain with neuron receptor

5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

BioWorld Science

Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...

MicroRNAs in circulating extracellular vesicles as IPF biomarkers

BioWorld Science

MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...